Concepedia

Publication | Open Access

Tegavivint and the β-Catenin/ALDH Axis in Chemotherapy-Resistant and Metastatic Osteosarcoma

DOIFull Paper Access

98

Citations

41

References

2019

Year

Motonari Nomura, Nino Rainusso, Yi‐Chien Lee, Brian Dawson, Cristian Coarfa, Ruolan Han, Jeffrey L. Larson, Ryan L. Shuck, Lyazat Kurenbekova, Jason T. Yustein
JNCI Journal of the National Cancer Institute

Abstract

Tegavivint is a promising therapeutic agent for advanced stages of OS via its targeting of the β-catenin/ALDH1 axis.

References

YearCitations

Page 1